Indian pharmaceutical companies have urged the government to pass legislation on data protection exclusivity.
Canadian drug maker Apotex has filed an appeal of a U.S. District Court ruling that found its generic divalproex sodium had infringed Abbott Laboratories' intellectual property covering epilepsy drug Depakote.
Poland will ask the European Commission for a 15-year transition period to conform to the European Union’s new regulatory framework for pharmaceutical patent protection.
Pfizer has filed a lawsuit against an online vendor of generic drugs, alleging that the website markets an illegal copy of cholesterol fighter Lipitor.
CollaGenex Pharmaceuticals has settled its patent litigation against Mutual Pharmaceuticals over a treatment for adult periodontitis, in an agreement that includes a licensing agreement and a $2 million payment to Mutual.
In a case likely to have broad implications, Swiss generic drug maker Sandoz has filed a lawsuit against the European Commission for denying approval of the world’s first generic biotech drug.
The U.S. District Court for the District of New Jersey has ruled that Ranbaxy Laboratories’ generic version of GlaxoSmithKline's antibiotic Ceftin does not infringe patents held by Glaxo.
The U.S. Court of Appeals for the Federal Circuit has upheld Genentech's legal victory in a $1 billion patent battle with biotechnology rival Chiron.
AstraZeneca has filed a patent infringement lawsuit in the U.S. District Court for the District of Delaware against Eon Labs based on the generic maker’s plan to make a copycat version of the hypertension drug Toprol-XL.
A coalition of U.N. agencies and charitable organizations including former U.S. President Bill Clinton’s foundation unveiled a plan to buy and distribute generic AIDS drugs to developing countries at deep discounts.
German drug maker Altana said it will take legal steps against a patent challenge for its ulcer drug pantoprazole from a generic competitor in the U.S., the company said in a statement on Monday.
The U.S. Federal Trade Commission has filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit, supporting Teva Pharmaceutical Industries Ltd. in its litigation against Pfizer over its right to make a generic version of the top-selling antidepressant Zoloft.
Diomed has sued rival Total Vein Solutions for alleged infringement of its patent for endovascular laser treatments of varicose veins.
Israel plans to make concessions to the U.S. on intellectual property issues in the pharmaceutical industry, a senior official told a business newspaper.
The European Patent Office has invalidated a patent for drug-coated stents, which has been at the center of a dispute between medical device makers Medinol and Boston Scientific in the Netherlands.
BioGentech Corp. has agreed to change its name to Cobalis Corp. as part of a settlement of a trademark infringement suit filed by Biogen Idec, a federal filing shows.
Kos Pharmaceutical has sued Barr Laboratories over its plans to make generic versions of two cholesterol drugs, Niaspan and Advicor.
A federal jury in Los Angeles has awarded $134.5 million in damages to medical device maker Masimo after finding that a unit of Tyco International willfully infringed four patents held by the company.
A federal judge has ruled that the claims of a patent at the center of a lawsuit filed by biotech company Cytomedix against a foot clinic should be broadly construed, according to the plaintiff.
Australian biotech company Benitec has filed patent infringement lawsuits in the U.S. District Court in Delaware against rivals Nucleonics, Inc., Ambion, Inc., and Genscript, alleging that the three companies infringe its gene silencing technologies.